MTOR and renal carcinoma: However, the dual effects of immunosuppressive and antitumor effects of phloretin are more suitable as immunosuppressive drugs for liver transplantation in patients with hepatocellular carcinoma or kidney transplantation in patients with renal cancer, just like rapamycin (a kind of mTOR inhibitor) [40, 41].